These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 2288524
1. [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia]. Scanavacca MI, Sosa EA, Lee JH, Bellotti G, Pileggi F. Arq Bras Cardiol; 1990 Jun; 54(6):367-71. PubMed ID: 2288524 [Abstract] [Full Text] [Related]
2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
3. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia]. Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R. Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771 [Abstract] [Full Text] [Related]
4. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up]. Di Pede F, Raviele A, Gasparini G, Caprioglio F, Zanocco A, Delise P, Bonso A, D'Este D, Piccolo E. G Ital Cardiol; 1990 Sep; 20(9):819-27. PubMed ID: 2079183 [Abstract] [Full Text] [Related]
5. [Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia]. Tonet J, Frank R, Fontaine G, Grosgogeat Y. Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1511-7. PubMed ID: 2573326 [Abstract] [Full Text] [Related]
6. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms. Masotti CS, Pierangeli A. Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709 [Abstract] [Full Text] [Related]
7. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S. J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400 [Abstract] [Full Text] [Related]
8. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. Kerin NZ, Rubenfire M, Blevins RD, Frumin H, Faitel K, Jarandilla R, Aragon E, Marinescu G, Luarca R. Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193 [Abstract] [Full Text] [Related]
9. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy]. Rosenbaum M, Posse R, Sgammini H, Núñez Burgos J, Chiale PA, Pastori JD, González Zuelgaray J, Brunetto JF, Califano JE. Arch Inst Cardiol Mex; 1987 Mar; 57(4):325-30. PubMed ID: 2445316 [Abstract] [Full Text] [Related]
10. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP. N Engl J Med; 1981 Sep 03; 305(10):539-45. PubMed ID: 6789201 [Abstract] [Full Text] [Related]
11. [Transcoronary chemical ablation of ventricular tachycardia in a patient with chronic chagas cardiomyopathy]. Sternick EB, Sobrinho AL, Lisboa JC, Barbosa MR, Fantini F, Gontijo Filho B, Vrandecic MO. Arq Bras Cardiol; 1992 Apr 03; 58(4):307-10. PubMed ID: 1340701 [Abstract] [Full Text] [Related]
13. [Medical treatment of sustained ventricular tachycardia. Retrospective study of 85 patients]. Artigou JY, Isnard R, Faure C, Frank R, Salloum J, Jauffrion P, Grosgogeat Y. Arch Mal Coeur Vaiss; 1989 Jul 03; 82(8):1415-20. PubMed ID: 2508593 [Abstract] [Full Text] [Related]
14. [Treatment of ventricular tachycardia in infancy and childhood with amiodarone]. Batisse A, Sardet A, Fermont L, Kachaner J. Arch Mal Coeur Vaiss; 1982 Aug 03; 75(8):829-35. PubMed ID: 6814383 [Abstract] [Full Text] [Related]
15. Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN. Ann Emerg Med; 2006 Mar 03; 47(3):217-24. PubMed ID: 16492484 [Abstract] [Full Text] [Related]
16. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. Raviele A, Di Pede F, Delise P, Piccolo E. G Ital Cardiol; 1984 Sep 03; 14(9):644-54. PubMed ID: 6510619 [Abstract] [Full Text] [Related]
17. [Long-term preventive effect and safety of amiodarone in patients with paroxysmal atrial fibrillation refractory to class I antiarrhythmic agents: analysis based on patient profiles]. Komatsu T, Horiuchi D, Nakamura S, Suzuki O, Yomogida K, Okumura K. J Cardiol; 2005 Jan 03; 45(1):11-7. PubMed ID: 15700925 [Abstract] [Full Text] [Related]
18. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC. J Cardiovasc Electrophysiol; 2007 Dec 03; 18(12):1236-40. PubMed ID: 17900257 [Abstract] [Full Text] [Related]
19. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia]. Mendoza I, Moleiro F, Castellanos A, Casal H, Arends E, Medina V. Arch Inst Cardiol Mex; 1982 Dec 03; 52(4):301-11. PubMed ID: 7138133 [Abstract] [Full Text] [Related]
20. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. Cassagneau B, Calazel J, Puel J, Massabuau P, Tournadre P, Fauvel JM, Bounhoure JP, Marin T, Narula OS. Arch Mal Coeur Vaiss; 1984 Jul 03; 77(7):766-72. PubMed ID: 6433839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]